Kodak is branching out into pharmaceuticals with US investment

Photo by Smith Collection/Gado/Getty Images Kodak, once a powerful force in photography, is branching out into pharmaceuticals and the US government plans to give the company a $765 million loan to support its efforts. Kodak will create a new business arm, Kodak Pharmaceuticals, to produce ingredients needed for drug manufacturing.
Kodak Pharmaceuticals will make ingredients that have “lapsed into chronic national shortage,” and once the unit is fully up and running, it will be able to make “up to 25 percent of active pharmaceutical ingredients used in non-biologic, non-antibacterial, generic pharmaceuticals,” Kodak estimates. Kodak CEO Jim Continenza expects pharmaceuticals to eventually comprise 30 to 40 percent of Kodak’s business, reports The Wall Street Journal.
The $765… Continue reading…

AMD says its PS5 and Xbox Series X chips, Zen 3 CPUs, and RDNA 2 GPUs will ship on time

The PS5 will feature a custom AMD Zen 2 processor | Image: Sony AMD CEO Lisa Su shared during the company’s second-quarter earnings call that its many anticipated product launches are still on schedule to release in 2020. This includes its 7nm processors based on Zen 3 architecture, and its RDNA 2 (or “Big Navi”) graphics cards. Su also shared that AMD began initial production and shipment of next-gen console chips, including for the PS5 and the Xbox Series X. Both consoles are set for release this holiday.
This is all good news for people hoping to upgrade their PCs with upcoming AMD parts, or those interested in buying a new console later this year. But it’s unfortunate for Intel, which recently suffered a few big product roadmap setbacks. Intel announced that it’s pushing back its already-delayed…
Continue reading…